asthma
copd
exacerb
identif
pathogen
nasopharyng
aspir
human
rhinoviru
hrv
type
common
hrva
hrvc
affect
clinic
outcom
except
identif
pathogen
asthma
exacerb
associ
lower
rate
readmiss
day
infecti
agent
recogn
major
pathogen
factor
acut
exacerb
copd
aecopd
asthma
contribut
factor
exacerb
includ
air
pollut
low
temperatur
interrupt
regular
treatment
studi
use
polymeras
chain
reaction
pcr
report
variabl
detect
rate
microorgan
patient
aecopd
asthma
exacerb
previou
studi
unit
kingdom
found
upper
respiratori
viral
infect
associ
asthma
exacerb
children
age
year
limit
data
viral
aetiolog
asthma
exacerb
adult
recent
studi
australia
found
viral
bacteri
mix
aetiolog
identifi
respect
asthma
exacerb
hospit
admiss
hrv
major
trigger
aecopd
asthma
exacerb
may
pose
signific
problem
diseas
manag
hrv
common
viru
found
aecopd
studi
report
among
viral
isol
among
respiratori
virus
hrv
infect
preced
mani
asthma
exacerb
children
type
hrv
character
classifi
group
hrva
hrvb
recent
hrvc
advanc
technolog
possibl
identifi
differ
group
hrv
best
knowledg
data
type
hrv
may
precipit
aecopd
limit
data
subtyp
hrv
relat
adult
asthma
exacerb
furthermor
unknown
certain
viral
infect
would
associ
wors
clinic
outcom
patient
prolong
hospit
length
stay
lo
readmiss
primari
aim
studi
evalu
preval
differ
virus
includ
type
hrv
relat
acut
exacerb
asthma
copd
secondari
aim
assess
certain
pathogen
associ
clinic
outcom
includ
durat
hospit
readmiss
mortal
subject
asthma
exacerb
aecopd
admit
princ
wale
hospit
aug
juli
screen
studi
aecopd
defin
patient
age
year
background
copd
lung
function
paramet
ratio
present
least
two
follow
major
symptom
increas
dyspnoea
increas
sputum
purul
increas
sputum
volum
one
major
one
minor
symptom
nasal
dischargecongest
wheez
sore
throat
cough
least
two
consecut
day
patient
asthma
exacerb
subject
age
year
background
asthma
consist
histori
prior
document
evid
variabl
airflow
obstruct
evid
increas
greater
ml
follow
bronchodil
bronchial
hyperrespons
bronchial
provoc
test
stabl
present
either
increas
dyspnea
wheez
cough
least
consecut
day
control
asthma
copd
subject
recruit
respiratori
clinic
princ
wale
hospit
recruit
copd
subject
ratio
asthma
patient
clinic
diagnosi
asthma
subject
exacerb
asthma
copd
week
prior
assess
patient
histori
lung
resect
signific
pulmonari
diseas
pulmonari
fibrosi
activ
infect
pulmonari
tuberculosi
short
life
expect
includ
subject
termin
malign
intract
heart
failur
exclud
studi
obtain
consent
patient
nasopharyng
aspir
npa
obtain
patient
within
day
hospit
exacerb
asthma
copd
studi
approv
joint
cuhkntec
clinic
research
ethic
committe
npa
specimen
collect
put
immedi
viral
transport
medium
kept
transport
viral
rna
dna
extract
specimen
use
viru
spin
kit
qiagen
germani
subject
complianc
european
union
invitro
diagnost
requir
respiratori
pathogen
coronaviru
human
metapneumoviru
influenza
includ
influenza
influenza
b
parainfluenza
rhinovirusenteroviru
rsva
rsvb
adenoviru
bocaviru
bordetella
pertussi
chlamydophila
pneumonia
legionella
pneumonia
mycoplasma
pneumonia
assess
pathofind
netherland
kit
accord
manufactur
instruct
realtim
multiplex
pcr
perform
rotorgen
mdx
instrument
qiagen
germani
detect
base
melt
curv
analysi
specimen
posit
hrventeroviru
subject
sequenc
work
viru
type
adopt
method
describ
previou
studi
subject
call
back
research
clinic
week
discharg
lung
function
assess
spirometri
pre
postbronchodil
accord
american
thorac
societi
european
respiratori
societi
standard
perform
updat
predict
spirometri
valu
hong
kong
chines
use
calcul
predict
lung
function
subsequ
hospit
admiss
mortal
record
baselin
assess
month
control
copd
asthma
patient
identifi
patient
outpati
clinic
call
back
patient
assess
singl
visit
obtain
npa
spirometri
test
visit
aim
recruit
episod
aecopd
episod
asthma
exacerb
number
exacerb
subject
control
given
potenti
season
variat
viral
etiolog
use
timestratifi
random
sampl
approach
patient
recruit
month
recruit
similar
number
subject
differ
categori
data
analyz
statist
packag
social
scienc
statist
softwar
spss
window
version
ibm
spss
inc
il
usa
descript
statist
appli
preval
differ
virus
found
aecopd
asthma
patient
comparison
control
subject
done
chisquar
test
fisher
exact
test
student
ttest
appropri
clinic
outcom
patient
differ
virus
compar
chisquar
test
student
ttest
test
appropri
figur
present
mean
sd
median
interquartil
rang
pvalu
consid
signific
aug
jul
recruit
patient
aecopd
stabl
copd
asthma
exacerb
stabl
asthma
subject
studi
characterist
copd
asthma
subject
shown
tabl
exacerb
stabl
state
subject
match
lung
function
age
gender
inhal
therapi
among
subject
aecopd
case
pathogen
detect
case
coinfect
pathogen
identifi
among
copd
control
subject
patient
pathogen
detect
none
pathogen
identifi
npa
preval
microorgan
identifi
copd
aecopd
stabl
patient
shown
fig
preval
microorgan
identifi
differ
month
shown
addit
file
figur
aecopd
group
asthma
exacerb
group
control
subject
influenza
identifi
rtpcr
npa
aecopd
asthma
exacerb
subject
subject
strain
identifi
respect
rest
influenza
belong
strain
aecopd
subject
pathogen
identifi
npa
similar
hospit
lo
vs
day
p
day
readmiss
vs
p
day
readmiss
vs
p
inhospit
mortal
vs
p
day
mortal
vs
p
day
mortal
vs
p
compar
without
isol
pathogen
among
subject
asthma
exacerb
pathogen
detect
subject
coinfect
pathogen
studi
among
asthma
control
subject
subject
parainfluenza
viru
detect
preval
microorgan
identifi
asthma
exacerb
asthma
stabl
patient
shown
fig
preval
microorgan
identifi
differ
month
shown
addit
file
figur
subject
asthma
exacerb
detect
pathogen
npa
similar
hospit
lo
vs
day
p
inhospit
mortal
vs
p
comparison
without
pathogen
mortal
record
discharg
patient
till
day
npa
posit
group
lower
day
vs
p
day
readmiss
vs
p
npa
neg
group
differ
rate
icu
admiss
noninvas
ventil
niv
use
mechan
ventil
support
among
microorgan
identifi
npa
vs
without
microorgan
identifi
asthma
copd
exacerb
result
shown
tabl
comparison
subject
without
influenza
vaccin
found
rate
influenzarel
exacerb
appear
higher
influenza
vaccin
reach
statist
signific
result
shown
tabl
hrv
detect
subject
respect
aecopd
asthma
exacerb
stabl
copd
subject
stabl
asthma
group
hrv
identifi
npa
subtyp
list
tabl
comparison
differ
type
hrv
hrva
hrvb
hrvc
identifi
found
associ
variou
type
hrv
aecopd
asthma
exacerb
hospit
lo
readmiss
mortal
result
relationship
hrv
type
clinic
outcom
aecopd
asthma
exacerb
shown
addit
file
tabl
respect
use
multiplex
molecular
detect
respiratori
pathogen
adult
hospit
aecopd
asthma
exacerb
studi
found
rate
pathogen
identif
npa
respect
rate
much
lower
among
correspond
control
copd
asthma
subject
respect
hrv
type
suggest
hrva
hrvc
common
hrv
associ
aecopd
asthma
exacerb
wide
varieti
genotyp
detect
microorgan
npa
hrv
type
otherwis
affect
clinic
outcom
includ
hospit
lo
readmiss
mortal
except
patient
asthma
exacerb
identif
pathogen
associ
lower
rate
readmiss
day
advanc
diagnost
technolog
rate
pathogen
identif
higher
current
studi
previou
studi
year
ago
vs
influenza
virus
remain
common
pathogen
identifi
studi
report
hrv
commonest
viru
identifi
contrast
rel
studi
report
influenza
frequent
found
viru
among
asthma
subject
pathogen
detect
studi
previou
studi
detect
respiratori
pathogen
asthma
exacerb
conduct
children
korean
studi
found
adult
asthma
subject
acut
exacerb
virus
identifi
expector
sputum
hrv
commonest
viru
detect
paediatr
studi
hong
kong
children
age
year
januari
februari
detect
respiratori
pathogen
subject
hrv
commonest
organ
identifi
adult
subject
asthma
exacerb
thu
appear
lower
rate
pathogen
identifi
children
season
variat
microorgan
identifi
npa
observ
studi
influenza
virus
reach
peak
novemb
februari
june
juli
aecopd
similar
pattern
observ
adult
asthma
exacerb
influenza
viru
detect
peak
novemb
june
juli
pattern
phase
influenza
season
pattern
hong
kong
studi
hrv
relat
exacerb
airway
diseas
uk
relat
childhood
asthma
season
increas
hrv
infect
septemb
decemb
spring
similar
pattern
note
adult
copd
asthma
exacerb
patient
studi
children
hrva
hrvc
frequent
associ
asthma
exacerb
crosssect
studi
subject
age
year
hong
kong
octob
march
found
asthma
exacerb
strongli
associ
hrv
specif
hrvc
infect
similar
observ
asthma
children
part
world
observ
hrvc
appear
strongli
associ
sever
exacerb
includ
requir
hospit
contrast
adult
asthma
exacerb
hrva
isol
npa
frequent
hrvc
pattern
thu
appear
differ
find
children
studi
japan
show
hrva
hrvc
potenti
role
precipit
asthma
attack
among
japanes
adult
patient
broad
genet
diverg
data
type
hrv
associ
aecopd
scarc
distinct
hrv
genotyp
includ
hrva
hrvb
serotyp
newli
identifi
hrvc
genotyp
hrv
structur
genet
variabl
inhibit
effort
develop
antivir
studi
copd
patient
gener
type
hrv
histori
influenza
vaccin
appear
higher
rate
identif
influenza
virus
npa
without
vaccin
aecopd
asthma
exacerb
though
reach
statist
signific
previou
studi
suggest
protect
serum
antibodi
titr
copd
patient
influenza
vaccin
lower
control
subject
overal
mortal
benefit
influenza
vaccin
copd
suggest
studi
impact
exacerb
prevent
less
clear
anoth
system
review
indic
favor
benefitrisk
ratio
season
influenza
vaccin
patient
copd
person
asthma
recent
systemat
review
observ
influenza
vaccin
might
effect
reduc
influenza
infect
asthma
attack
howev
anoth
cochran
review
express
uncertainti
degre
protect
influenza
vaccin
might
confer
asthma
exacerb
relat
influenza
infect
studi
period
august
juli
influenza
main
circul
strain
caus
summer
winter
epidem
hong
kong
influenza
vaccin
effect
depend
mani
factor
includ
match
vaccin
strain
circul
strain
immunocompet
age
repeat
vaccin
antigen
site
distanc
addit
egg
adapt
especi
influenza
viru
previou
systemat
review
found
substanti
variat
influenza
vaccin
effect
across
type
subtyp
influenza
substanti
lower
protect
examin
influenza
vaccin
effect
serolog
beyond
scope
studi
would
requir
larg
sampl
size
addit
patient
time
delay
present
hospit
would
difficult
determin
whether
due
current
previou
infect
vaccin
measur
influenza
antibodi
base
haemagglutinin
inhibit
identif
pathogen
npa
associ
lower
rate
readmiss
asthma
exacerb
copd
asthma
might
also
due
acut
transient
factor
exposur
air
pollut
chang
temperatur
etc
one
limit
studi
singlecentr
studi
studi
mainli
aim
assess
subject
exacerb
state
number
exacerb
subject
recruit
control
furthermor
subject
test
exacerb
due
limit
budget
exacerb
stabl
state
subject
match
gender
age
inhal
therapi
factor
might
associ
aecopd
asthma
exacerb
eg
air
pollut
weather
chang
allerg
sensit
etc
investig
bacteri
infect
might
also
play
part
aecopd
assess
studi
interact
microorgan
factor
air
pollut
weather
may
import
although
viral
atyp
bacteria
identifi
subject
exacerb
could
establish
caus
role
stabl
subject
also
pathogen
identifi
npa
subject
involv
studi
sever
airway
diseas
exacerb
requir
hospit
result
could
extrapol
milder
ill
manag
commun
result
studi
provid
latest
pattern
viral
atyp
pathogen
associ
aecopd
asthma
exacerb
hospit
patient
hrv
type
suggest
hrva
hrvc
common
hrv
subtyp
associ
aecopd
asthma
exacerb
wide
varieti
genotyp
presenc
microorgan
npa
hrv
type
otherwis
affect
clinic
outcom
includ
hospit
lo
readmiss
mortal
except
patient
infect
aetiolog
identifi
asthma
exacerb
lower
rate
readmiss
day
